the results of the study carried out for more than 2 years indicate that the depot formulation of medroxyprogesterone acetate ( dmpa , depo-provera ) at a dose of 150 mg at 90-day intervals appears to be acceptable to some women of this part of india , though many of them experience menstrual problems .
C0065864
medroxyprogesterone acetate
C0699700
depo-provera